What's new

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

May 15, 2025 - 12:10
 0
Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

FDA delays decision on Biohaven's rare disease drug filing, plans adcomm

Next Article

Human medicines European public assessment report (EPAR): Eltrombopag Accord, el...

Related Posts

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Date of authorisation: 08/12/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Frequently asked questions on the European Shortages Mo...

May 13, 2025  0